GenOdyssee SA Announces Research Partnership with Baxter AG

25-Oct-2006

GenOdyssee S.A., a biotechnology company dedicated to the discovery of novel protein therapeutic products, has entered into a research and development cooperation agreement with Baxter AG. GenOdyssee will use its unique intellectual property position in the field of protein therapeutics, as well as its proprietary technology and integrated processes, in the discovery of novel blood clotting factors. Under the agreement, any resulting commercially viable products will be developed and brought to market by Baxter AG.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances